Table of Content

1 Study Coverage
1.1 Viral Gastroenteritis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Viral Gastroenteritis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antibiotic
1.2.3 Antacids
1.2.4 Antikinetic Agent
1.2.5 Other
1.3 Market by Application
1.3.1 Global Viral Gastroenteritis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Viral Gastroenteritis Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Viral Gastroenteritis Drugs Revenue by Region
2.2.1 Global Viral Gastroenteritis Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Viral Gastroenteritis Drugs Revenue by Region (2018-2024)
2.2.3 Global Viral Gastroenteritis Drugs Revenue by Region (2024-2029)
2.2.4 Global Viral Gastroenteritis Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Viral Gastroenteritis Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Viral Gastroenteritis Drugs Sales by Region
2.4.1 Global Viral Gastroenteritis Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Viral Gastroenteritis Drugs Sales by Region (2018-2024)
2.4.3 Global Viral Gastroenteritis Drugs Sales by Region (2024-2029)
2.4.4 Global Viral Gastroenteritis Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Viral Gastroenteritis Drugs Sales by Manufacturers
3.1.1 Global Viral Gastroenteritis Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Viral Gastroenteritis Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Viral Gastroenteritis Drugs in 2022
3.2 Global Viral Gastroenteritis Drugs Revenue by Manufacturers
3.2.1 Global Viral Gastroenteritis Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Viral Gastroenteritis Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Viral Gastroenteritis Drugs Revenue in 2022
3.3 Global Key Players of Viral Gastroenteritis Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Viral Gastroenteritis Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Viral Gastroenteritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Viral Gastroenteritis Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Viral Gastroenteritis Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Viral Gastroenteritis Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Viral Gastroenteritis Drugs Sales by Type
4.1.1 Global Viral Gastroenteritis Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Viral Gastroenteritis Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2029)
4.2 Global Viral Gastroenteritis Drugs Revenue by Type
4.2.1 Global Viral Gastroenteritis Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Viral Gastroenteritis Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Viral Gastroenteritis Drugs Price by Type
4.3.1 Global Viral Gastroenteritis Drugs Price by Type (2018-2024)
4.3.2 Global Viral Gastroenteritis Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Viral Gastroenteritis Drugs Sales by Application
5.1.1 Global Viral Gastroenteritis Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Viral Gastroenteritis Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2029)
5.2 Global Viral Gastroenteritis Drugs Revenue by Application
5.2.1 Global Viral Gastroenteritis Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Viral Gastroenteritis Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Viral Gastroenteritis Drugs Price by Application
5.3.1 Global Viral Gastroenteritis Drugs Price by Application (2018-2024)
5.3.2 Global Viral Gastroenteritis Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Viral Gastroenteritis Drugs Market Size by Type
6.1.1 US & Canada Viral Gastroenteritis Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Viral Gastroenteritis Drugs Revenue by Type (2018-2029)
6.2 US & Canada Viral Gastroenteritis Drugs Market Size by Application
6.2.1 US & Canada Viral Gastroenteritis Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Viral Gastroenteritis Drugs Revenue by Application (2018-2029)
6.3 US & Canada Viral Gastroenteritis Drugs Market Size by Country
6.3.1 US & Canada Viral Gastroenteritis Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Viral Gastroenteritis Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Viral Gastroenteritis Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Viral Gastroenteritis Drugs Market Size by Type
7.1.1 Europe Viral Gastroenteritis Drugs Sales by Type (2018-2029)
7.1.2 Europe Viral Gastroenteritis Drugs Revenue by Type (2018-2029)
7.2 Europe Viral Gastroenteritis Drugs Market Size by Application
7.2.1 Europe Viral Gastroenteritis Drugs Sales by Application (2018-2029)
7.2.2 Europe Viral Gastroenteritis Drugs Revenue by Application (2018-2029)
7.3 Europe Viral Gastroenteritis Drugs Market Size by Country
7.3.1 Europe Viral Gastroenteritis Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Viral Gastroenteritis Drugs Sales by Country (2018-2029)
7.3.3 Europe Viral Gastroenteritis Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Viral Gastroenteritis Drugs Market Size
8.1.1 China Viral Gastroenteritis Drugs Sales (2018-2029)
8.1.2 China Viral Gastroenteritis Drugs Revenue (2018-2029)
8.2 China Viral Gastroenteritis Drugs Market Size by Application
8.2.1 China Viral Gastroenteritis Drugs Sales by Application (2018-2029)
8.2.2 China Viral Gastroenteritis Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Viral Gastroenteritis Drugs Market Size by Type
9.1.1 Asia Viral Gastroenteritis Drugs Sales by Type (2018-2029)
9.1.2 Asia Viral Gastroenteritis Drugs Revenue by Type (2018-2029)
9.2 Asia Viral Gastroenteritis Drugs Market Size by Application
9.2.1 Asia Viral Gastroenteritis Drugs Sales by Application (2018-2029)
9.2.2 Asia Viral Gastroenteritis Drugs Revenue by Application (2018-2029)
9.3 Asia Viral Gastroenteritis Drugs Sales by Region
9.3.1 Asia Viral Gastroenteritis Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Viral Gastroenteritis Drugs Revenue by Region (2018-2029)
9.3.3 Asia Viral Gastroenteritis Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Overview
11.2.3 AbbVie Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AbbVie Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AbbVie Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Overview
11.3.3 Bayer AG Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bayer AG Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer AG Recent Developments
11.4 Sanofi S.A.
11.4.1 Sanofi S.A. Company Information
11.4.2 Sanofi S.A. Overview
11.4.3 Sanofi S.A. Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sanofi S.A. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi S.A. Recent Developments
11.5 AstraZeneca Plc.
11.5.1 AstraZeneca Plc. Company Information
11.5.2 AstraZeneca Plc. Overview
11.5.3 AstraZeneca Plc. Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 AstraZeneca Plc. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Plc. Recent Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Overview
11.6.3 Abbott Laboratories Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Abbott Laboratories Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Abbott Laboratories Recent Developments
11.7 GlaxoSmithKline Plc.
11.7.1 GlaxoSmithKline Plc. Company Information
11.7.2 GlaxoSmithKline Plc. Overview
11.7.3 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline Plc. Recent Developments
11.8 Takeda Pharmaceutical Company Limited
11.8.1 Takeda Pharmaceutical Company Limited Company Information
11.8.2 Takeda Pharmaceutical Company Limited Overview
11.8.3 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Takeda Pharmaceutical Company Limited Recent Developments
11.9 EliLilly and Company
11.9.1 EliLilly and Company Company Information
11.9.2 EliLilly and Company Overview
11.9.3 EliLilly and Company Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 EliLilly and Company Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 EliLilly and Company Recent Developments
11.10 Amgen Inc
11.10.1 Amgen Inc Company Information
11.10.2 Amgen Inc Overview
11.10.3 Amgen Inc Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Amgen Inc Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Inc Recent Developments
11.11 C.H.Boehringer Sohn AG & Co.KG
11.11.1 C.H.Boehringer Sohn AG & Co.KG Company Information
11.11.2 C.H.Boehringer Sohn AG & Co.KG Overview
11.11.3 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 C.H.Boehringer Sohn AG & Co.KG Recent Developments
11.12 Daiichi Sankyo Company Limited
11.12.1 Daiichi Sankyo Company Limited Company Information
11.12.2 Daiichi Sankyo Company Limited Overview
11.12.3 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Daiichi Sankyo Company Limited Recent Developments
11.13 Regeneron Pharmaceuticals lInc.
11.13.1 Regeneron Pharmaceuticals lInc. Company Information
11.13.2 Regeneron Pharmaceuticals lInc. Overview
11.13.3 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Regeneron Pharmaceuticals lInc. Recent Developments
11.14 Mylan N.V.
11.14.1 Mylan N.V. Company Information
11.14.2 Mylan N.V. Overview
11.14.3 Mylan N.V. Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Mylan N.V. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Mylan N.V. Recent Developments
11.15 Astellas Pharma Inc.
11.15.1 Astellas Pharma Inc. Company Information
11.15.2 Astellas Pharma Inc. Overview
11.15.3 Astellas Pharma Inc. Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Astellas Pharma Inc. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Astellas Pharma Inc. Recent Developments
11.16 Fresenius Kabi AG
11.16.1 Fresenius Kabi AG Company Information
11.16.2 Fresenius Kabi AG Overview
11.16.3 Fresenius Kabi AG Viral Gastroenteritis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Fresenius Kabi AG Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Fresenius Kabi AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Viral Gastroenteritis Drugs Industry Chain Analysis
12.2 Viral Gastroenteritis Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Viral Gastroenteritis Drugs Production Mode & Process
12.4 Viral Gastroenteritis Drugs Sales and Marketing
12.4.1 Viral Gastroenteritis Drugs Sales Channels
12.4.2 Viral Gastroenteritis Drugs Distributors
12.5 Viral Gastroenteritis Drugs Customers
13 Market Dynamics
13.1 Viral Gastroenteritis Drugs Industry Trends
13.2 Viral Gastroenteritis Drugs Market Drivers
13.3 Viral Gastroenteritis Drugs Market Challenges
13.4 Viral Gastroenteritis Drugs Market Restraints
14 Key Findings in The Global Viral Gastroenteritis Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Viral Gastroenteritis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Antibiotic
Table 3. Major Manufacturers of Antacids
Table 4. Major Manufacturers of Antikinetic Agent
Table 5. Major Manufacturers of Other
Table 6. Global Viral Gastroenteritis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Viral Gastroenteritis Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Viral Gastroenteritis Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Viral Gastroenteritis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Viral Gastroenteritis Drugs Revenue Market Share by Region (2018-2024)
Table 11. Global Viral Gastroenteritis Drugs Revenue Market Share by Region (2024-2029)
Table 12. Global Viral Gastroenteritis Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Viral Gastroenteritis Drugs Sales by Region (2018-2024) & (K Units)
Table 14. Global Viral Gastroenteritis Drugs Sales by Region (2024-2029) & (K Units)
Table 15. Global Viral Gastroenteritis Drugs Sales Market Share by Region (2018-2024)
Table 16. Global Viral Gastroenteritis Drugs Sales Market Share by Region (2024-2029)
Table 17. Global Viral Gastroenteritis Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Viral Gastroenteritis Drugs Sales Share by Manufacturers (2018-2024)
Table 19. Global Viral Gastroenteritis Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Viral Gastroenteritis Drugs Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Viral Gastroenteritis Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Viral Gastroenteritis Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Viral Gastroenteritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Viral Gastroenteritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gastroenteritis Drugs as of 2022)
Table 25. Global Key Manufacturers of Viral Gastroenteritis Drugs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Viral Gastroenteritis Drugs, Product Offered and Application
Table 27. Global Key Manufacturers of Viral Gastroenteritis Drugs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (K Units)
Table 30. Global Viral Gastroenteritis Drugs Sales by Type (2024-2029) & (K Units)
Table 31. Global Viral Gastroenteritis Drugs Sales Share by Type (2018-2024)
Table 32. Global Viral Gastroenteritis Drugs Sales Share by Type (2024-2029)
Table 33. Global Viral Gastroenteritis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Viral Gastroenteritis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Viral Gastroenteritis Drugs Revenue Share by Type (2018-2024)
Table 36. Global Viral Gastroenteritis Drugs Revenue Share by Type (2024-2029)
Table 37. Viral Gastroenteritis Drugs Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Viral Gastroenteritis Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (K Units)
Table 40. Global Viral Gastroenteritis Drugs Sales by Application (2024-2029) & (K Units)
Table 41. Global Viral Gastroenteritis Drugs Sales Share by Application (2018-2024)
Table 42. Global Viral Gastroenteritis Drugs Sales Share by Application (2024-2029)
Table 43. Global Viral Gastroenteritis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Viral Gastroenteritis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Viral Gastroenteritis Drugs Revenue Share by Application (2018-2024)
Table 46. Global Viral Gastroenteritis Drugs Revenue Share by Application (2024-2029)
Table 47. Viral Gastroenteritis Drugs Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Viral Gastroenteritis Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Viral Gastroenteritis Drugs Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Viral Gastroenteritis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Viral Gastroenteritis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Viral Gastroenteritis Drugs Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Viral Gastroenteritis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Viral Gastroenteritis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Viral Gastroenteritis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Viral Gastroenteritis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Viral Gastroenteritis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 62. Europe Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (K Units)
Table 63. Europe Viral Gastroenteritis Drugs Sales by Type (2024-2029) & (K Units)
Table 64. Europe Viral Gastroenteritis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Viral Gastroenteritis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (K Units)
Table 67. Europe Viral Gastroenteritis Drugs Sales by Application (2024-2029) & (K Units)
Table 68. Europe Viral Gastroenteritis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Viral Gastroenteritis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Viral Gastroenteritis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Viral Gastroenteritis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Viral Gastroenteritis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 74. Europe Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 75. China Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (K Units)
Table 76. China Viral Gastroenteritis Drugs Sales by Type (2024-2029) & (K Units)
Table 77. China Viral Gastroenteritis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Viral Gastroenteritis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (K Units)
Table 80. China Viral Gastroenteritis Drugs Sales by Application (2024-2029) & (K Units)
Table 81. China Viral Gastroenteritis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Viral Gastroenteritis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (K Units)
Table 84. Asia Viral Gastroenteritis Drugs Sales by Type (2024-2029) & (K Units)
Table 85. Asia Viral Gastroenteritis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Viral Gastroenteritis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (K Units)
Table 88. Asia Viral Gastroenteritis Drugs Sales by Application (2024-2029) & (K Units)
Table 89. Asia Viral Gastroenteritis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Viral Gastroenteritis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Viral Gastroenteritis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Viral Gastroenteritis Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Viral Gastroenteritis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Viral Gastroenteritis Drugs Sales by Region (2018-2024) & (K Units)
Table 95. Asia Viral Gastroenteritis Drugs Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 109. Pfizer Company Information
Table 110. Pfizer Description and Major Businesses
Table 111. Pfizer Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Pfizer Recent Developments
Table 114. AbbVie Company Information
Table 115. AbbVie Description and Major Businesses
Table 116. AbbVie Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. AbbVie Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. AbbVie Recent Developments
Table 119. Bayer AG Company Information
Table 120. Bayer AG Description and Major Businesses
Table 121. Bayer AG Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Bayer AG Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Bayer AG Recent Developments
Table 124. Sanofi S.A. Company Information
Table 125. Sanofi S.A. Description and Major Businesses
Table 126. Sanofi S.A. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Sanofi S.A. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Sanofi S.A. Recent Developments
Table 129. AstraZeneca Plc. Company Information
Table 130. AstraZeneca Plc. Description and Major Businesses
Table 131. AstraZeneca Plc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. AstraZeneca Plc. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. AstraZeneca Plc. Recent Developments
Table 134. Abbott Laboratories Company Information
Table 135. Abbott Laboratories Description and Major Businesses
Table 136. Abbott Laboratories Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Abbott Laboratories Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Abbott Laboratories Recent Developments
Table 139. GlaxoSmithKline Plc. Company Information
Table 140. GlaxoSmithKline Plc. Description and Major Businesses
Table 141. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. GlaxoSmithKline Plc. Recent Developments
Table 144. Takeda Pharmaceutical Company Limited Company Information
Table 145. Takeda Pharmaceutical Company Limited Description and Major Businesses
Table 146. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Takeda Pharmaceutical Company Limited Recent Developments
Table 149. EliLilly and Company Company Information
Table 150. EliLilly and Company Description and Major Businesses
Table 151. EliLilly and Company Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. EliLilly and Company Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. EliLilly and Company Recent Developments
Table 154. Amgen Inc Company Information
Table 155. Amgen Inc Description and Major Businesses
Table 156. Amgen Inc Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Amgen Inc Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Amgen Inc Recent Developments
Table 159. C.H.Boehringer Sohn AG & Co.KG Company Information
Table 160. C.H.Boehringer Sohn AG & Co.KG Description and Major Businesses
Table 161. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. C.H.Boehringer Sohn AG & Co.KG Recent Developments
Table 164. Daiichi Sankyo Company Limited Company Information
Table 165. Daiichi Sankyo Company Limited Description and Major Businesses
Table 166. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Daiichi Sankyo Company Limited Recent Developments
Table 169. Regeneron Pharmaceuticals lInc. Company Information
Table 170. Regeneron Pharmaceuticals lInc. Description and Major Businesses
Table 171. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Regeneron Pharmaceuticals lInc. Recent Developments
Table 174. Mylan N.V. Company Information
Table 175. Mylan N.V. Description and Major Businesses
Table 176. Mylan N.V. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Mylan N.V. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Mylan N.V. Recent Developments
Table 179. Astellas Pharma Inc. Company Information
Table 180. Astellas Pharma Inc. Description and Major Businesses
Table 181. Astellas Pharma Inc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Astellas Pharma Inc. Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Astellas Pharma Inc. Recent Developments
Table 184. Fresenius Kabi AG Company Information
Table 185. Fresenius Kabi AG Description and Major Businesses
Table 186. Fresenius Kabi AG Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Fresenius Kabi AG Viral Gastroenteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Fresenius Kabi AG Recent Developments
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Viral Gastroenteritis Drugs Distributors List
Table 192. Viral Gastroenteritis Drugs Customers List
Table 193. Viral Gastroenteritis Drugs Market Trends
Table 194. Viral Gastroenteritis Drugs Market Drivers
Table 195. Viral Gastroenteritis Drugs Market Challenges
Table 196. Viral Gastroenteritis Drugs Market Restraints
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Gastroenteritis Drugs Product Picture
Figure 2. Global Viral Gastroenteritis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Viral Gastroenteritis Drugs Market Share by Type in 2022 & 2029
Figure 4. Antibiotic Product Picture
Figure 5. Antacids Product Picture
Figure 6. Antikinetic Agent Product Picture
Figure 7. Other Product Picture
Figure 8. Global Viral Gastroenteritis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Viral Gastroenteritis Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Viral Gastroenteritis Drugs Report Years Considered
Figure 14. Global Viral Gastroenteritis Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Viral Gastroenteritis Drugs Revenue 2018-2029 (US$ Million)
Figure 16. Global Viral Gastroenteritis Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Viral Gastroenteritis Drugs Revenue Market Share by Region (2018-2029)
Figure 18. Global Viral Gastroenteritis Drugs Sales 2018-2029 ((K Units)
Figure 19. Global Viral Gastroenteritis Drugs Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Viral Gastroenteritis Drugs Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Viral Gastroenteritis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Viral Gastroenteritis Drugs Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Viral Gastroenteritis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Viral Gastroenteritis Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. China Viral Gastroenteritis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Viral Gastroenteritis Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Viral Gastroenteritis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Viral Gastroenteritis Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Viral Gastroenteritis Drugs in the World: Market Share by Viral Gastroenteritis Drugs Revenue in 2022
Figure 32. Global Viral Gastroenteritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2029)
Figure 34. Global Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2029)
Figure 35. Global Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2029)
Figure 36. Global Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Viral Gastroenteritis Drugs Revenue Share by Country (2018-2029)
Figure 42. US & Canada Viral Gastroenteritis Drugs Sales Share by Country (2018-2029)
Figure 43. U.S. Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2029)
Figure 46. Europe Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2029)
Figure 47. Europe Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2029)
Figure 48. Europe Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2029)
Figure 49. Europe Viral Gastroenteritis Drugs Revenue Share by Country (2018-2029)
Figure 50. Europe Viral Gastroenteritis Drugs Sales Share by Country (2018-2029)
Figure 51. Germany Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. France Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. China Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2029)
Figure 57. China Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2029)
Figure 58. China Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2029)
Figure 59. China Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2029)
Figure 60. Asia Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2029)
Figure 61. Asia Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2029)
Figure 62. Asia Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2029)
Figure 63. Asia Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2029)
Figure 64. Asia Viral Gastroenteritis Drugs Revenue Share by Region (2018-2029)
Figure 65. Asia Viral Gastroenteritis Drugs Sales Share by Region (2018-2029)
Figure 66. Japan Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. India Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Viral Gastroenteritis Drugs Sales Share by Country (2018-2029)
Figure 77. Brazil Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Viral Gastroenteritis Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Viral Gastroenteritis Drugs Value Chain
Figure 83. Viral Gastroenteritis Drugs Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed